Insider · CIK 0001979732
Michael Allen Jerman
Files at INTI (Inhibitor Therapeutics, Inc.), TCRT (Alaunos Therapeutics, Inc.). First filing -, latest -.
Michael Allen Jerman files SEC Form 4 as director at INTI (Inhibitor Therapeutics, Inc.), and also at TCRT (Alaunos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael Allen Jerman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +20,990 | $0.74 | $16k | 44,749 | 5 d ago |
| Apr 29, 2026 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +6,032 | $2.59 | $16k | 15,621 | May 1, 2026 |
| Jan 12, 2026 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +5,406 | $2.89 | $16k | 9,589 | Jan 15, 2026 |
| Nov 21, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Common Stock | +4,183 | $3.16 | $13k | 4,183 | Nov 26, 2025 |
| Jul 15, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jul 17, 2025 |
| Jul 15, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +3,200 | $0.00 | $0 | 3,200 | Jul 17, 2025 |
| Apr 1, 2025 | INTI Inhibitor Therapeutics, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 80,411 | Apr 7, 2025 |
Questions about Michael Allen Jerman
Answered from the filings on this page, as of the latest one.
Is Michael Allen Jerman buying or selling?
Michael Allen Jerman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael Allen Jerman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Allen Jerman has 0.
Where does Michael Allen Jerman file Form 4?
Michael Allen Jerman has filed Form 4 at INTI (Inhibitor Therapeutics, Inc.); TCRT (Alaunos Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.